Potential Application of HIF-PH Inhibitors to Treat Kidney Diseases

Front Biosci (Landmark Ed). 2026 Apr 21;31(4):47718. doi: 10.31083/FBL47718.ABSTRACTHypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitors have recently been approved for clinical use in the treatment of renal anemia. HIF-PH inhibitors were developed following studies investigating the role

Y Yuichiro Izumi

Comparative Effectiveness of High-Dose and Standard-Dose Influenza Vaccines for Hospitalisation and Mortality in Adults Aged 65 and Older: An Updated Systematic Review and Meta-Analysis

Rev Med Virol. 2026 May;36(3):e70158. doi: 10.1002/rmv.70158.ABSTRACTThis updated systematic review and meta-analysis evaluated the relative vaccine effectiveness (rVE) of high-dose inactivated influenza vaccine (HD-IV) versus standard-dose (SD-IV) in adults ≥ 65 years for key clinical outcomes, inc

B Bilal Wazir Khan

Paraoxonase 2 as a target for aging-related diseases

Korean J Physiol Pharmacol. 2026 Apr 29. doi: 10.4196/kjpp.25.354. Online ahead of print.ABSTRACTParaoxonase 2 (PON2) is an enzyme exhibiting both lactonase and esterase activities, widely distributed across various tissues and localized within cellular mitochondria. It plays a vital role in innate

H Hyeong Hwan Kim

Mortality in Relation to Brachial Versus Central Ambulatory Blood Pressure

Hypertension. 2026 Apr 29. doi: 10.1161/HYPERTENSIONAHA.126.26778. Online ahead of print.ABSTRACTBACKGROUND: Whether central systolic blood pressure (cSBP) compared with brachial systolic blood pressure (bSBP) improves risk stratification remains debated. This study investigated whether cSBP is more

D De-Wei An

Fibromuscular Dysplasia: Emerging Concepts Beyond the International Consensus

Hypertension. 2026 Apr 29. doi: 10.1161/HYPERTENSIONAHA.125.25633. Online ahead of print.ABSTRACTThe First International Consensus on the diagnosis and management of fibromuscular dysplasia is a landmark document. Since its publication in 2019, important research has been ongoing in the field. In th

T Tom Robberechts

Evaluating ejection dynamic parameters for assessing severe aortic stenosis

Caspian J Intern Med. 2026 Jan 21;17(1):106-112. doi: 10.22088/cjim.17.1.106. eCollection 2026.ABSTRACTBACKGROUND: Accurate diagnosis of aortic stenosis (AS) severity is crucial for effective treatment. This study aimed to define cutoff values for aortic ejection dynamic parameters, including ejecti

M Mohammad Reza Aghajankhah